Nomograms to predict survival outcomes after microwave ablation in elderly patients (>65 years old) with early-stage hepatocellular carcinoma

References

• Oweira H, Petrausch U, Helbling D, et al. Early stage hepatocellular carcinoma in the elderly: a SEER database analysis. J Geriatr Oncol. 2017;8(4):277–283.
   PubMed Web of Science ®Google Scholar
• Ueno M, Hayami S, Tani M, et al. Recent trends in hepatectomy for elderly patients with hepatocellular carcinoma. Surg Today. 2014;44(9):1651–1659.
   PubMed Web of Science ®Google Scholar
• Njei B, Rotman Y, Ditah I, et al. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61(1):191–199.
   PubMed Web of Science ®Google Scholar
• Pignata S, Gallo C, Daniele B, et al. Crit Rev Oncol Hematol. 2006;59(3):243–249.
   Google Scholar
• Guo H, Wu T, Lu Q, et al. Hepatocellular carcinoma in elderly: characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP)linical characteristics, treatments and outcomes compared with younger adults. PLOS One. 2017;12(9):e0184160.
   PubMed Web of Science ®Google Scholar
• Okamura Y, Sugiura T, Ito T, et al. The short- and long-term outcomes in elderly patients with hepatocellular carcinoma after curative surgery: a case-controlled study with propensity score matching. Eur Surg Res. 2018;59(5–6):380–390.
   PubMed Web of Science ®Google Scholar
• Mastoraki A, Tsakali A, Papanikolaou IS, et al. Outcome following major hepatic resection in the elderly patients. Clin Res Hepatol Gastroenterol. 2014;38(4):462–466.
   PubMed Web of Science ®Google Scholar
• Brozzetti S, Bezzi M, De Sanctis GM, et al. Elderly and very elderly patients with hepatocellular carcinoma. Strategy for a first line treatment. Ann Ital Chir. 2014;85:120–128.
   PubMed Web of Science ®Google Scholar
• Cho E, Cho HA, Jun CH, et al. A review of hepatocellular carcinoma in elderly patients focused on management and outcomes. In Vivo. 2019;33(5):1411–1420.
   PubMed Web of Science ®Google Scholar
• Shen X, Ma S, Tang X, et al. Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): a Strobe-compliant observational study. Medicine (Baltimore). 2018;97(35):e11618.
   PubMed Web of Science ®Google Scholar
• Wang YM, Qian GJ, Xu Y, et al. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases]. Zhonghua Gan Zang Bing Za Zhi. 2017;25(5):344–348.
   PubMedGoogle Scholar
• Groeschl RT, Pilgrim CH, Hanna EM, et al. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Ann Surg. 2014;(6)259:1195–1200.
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e180.
   PubMed Web of Science ®Google Scholar
• Takuma Y, Shota I, Miyatake H, et al. Nomograms to predict the disease-free survival and overall survival after radiofrequency ablation for hepatocellular carcinoma. Intern Med. 2018;57(4):457–468.
   PubMed Web of Science ®Google Scholar
• Ye L, Shi S, Zeng Z, et al. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy. Jpn J Clin Oncol. 2018;48(2):160–166.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020–1022.
   PubMed Web of Science ®Google Scholar
• Ni JY, An C, Zhang TQ, et al. Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma. Int J Hyperthermia. 2019;36:328–336.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Wan S, Nie Y, Zhu X. Development of a prognostic scoring model for predicting the survival of elderly patients with hepatocellular carcinoma. Peer J. 2020;8:e8497.
   PubMed Web of Science ®Google Scholar
• Ozenne V, Bouattour M, Goutté N, et al. Prospective evaluation of the management of hepatocellular carcinoma in the elderly. Dig Liver Dis. 2011;43(12):1001–1005.
   PubMedGoogle Scholar
• Bove A, Bongarzoni G, Di RRM, et al. Efficacy and safety of ablative techniques in elderly HCC patients. Ann Ital Chir. 2011;82(6):457–463.
   PubMed Web of Science ®Google Scholar
• Shin J, Yu JH, Jin YJ, et al. Effective therapeutic options for elderly patients with hepatocellular carcinoma: a nationwide cohort study. Medicine (Baltimore). 2019;98(30):e16150.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y, Iguchi E, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients. J Gastrointestin Liver Dis. 2012;21:397–405.
   PubMed Web of Science ®Google Scholar
• Yu B, Ding Y, Liao X, et al. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage. Saudi J Gastroenterol. 2018;24(6):317–325.
   PubMed Web of Science ®Google Scholar
• Peng ZW, Liu FR, Ye S, et al. Radiofrequency ablation versus open hepatic resection for elderly patients (>65 years) with very early or early hepatocellular carcinoma. Cancer. 2013;119(21):3812–3820.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P. Status and advancement of microwave ablation in China. Int J Hyperthermia. 2017;33(3):278–287.
   Google Scholar
• Ding J, Zhou Y, Wang Y, et al. Percutaneous microwave ablation of exophytic tumours in hepatocellular carcinoma patients: Safe or not. Liver Int. 2017;37(9):1365–1372.
   PubMed Web of Science ®Google Scholar
• Liang P, Yu J, Yu XL, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: a multicentre analysis of 1363 treatment-naive lesions in 1007 patients in China. Gut. 2012;61(7):1100–1101.
   PubMed Web of Science ®Google Scholar
• He W, Peng B, Tang Y, et al. Nomogram to predict survival of patients with recurrence of hepatocellular carcinoma after surgery. Clin Gastroenterol Hepatol. 2018;16(5):756–764.e10.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang H, Wen J, et al. Nomograms forecasting long-term overall and cancer-specific survival of patients with oral squamous cell carcinoma. Cancer Med. 2018;7(4):943–952.
   PubMed Web of Science ®Google Scholar
• Shim JH, Jun MJ, Han S, et al. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma. Ann Surg. 2015;261(5):939–946.
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, et al. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370.
   PubMed Web of Science ®Google Scholar